Background: Primary high-risk human papillomavirus (hr-HPV) testing of self-collected
cervico-vaginal swabs could increase cervical cancer screening coverage, although triage …

In the context of cervical cancer prevention, where human papillomavirus (HPV) infection is
pivotal, HPV testing is replacing Pap Smear in primary screening. This transition offers an …

Background/Objective Human papillomavirus (HPV) genotyping and cytology have been
recommended for colposcopy triage, but it is unclear which combinations of high-risk HPV …

Objectives The objective of the present study is to assess the performance of a high-risk
human papillomavirus (HR-HPV) DNA test with individual HPV-16/HPV-18 genotyping as a …

Background In cervical cancer screening programs, women with abnormal cytology are
referred for colposcopy for histological evaluation. We examined whether a human …

Objective To evaluate partial HPV16/18 genotyping as a possible biomarker to select
women attending HPV‐based cervical cancer screening at higher risk to be referred to …

Background: High-risk human papillomavirus (HR-HPV) testing has become a preferred
cervical cancer screening strategy in some countries due to its superior sensitivity over …

Background This study aimed to evaluate three different patterns of cervical cancer
screening strategies for detection of cervical diseases. Methods In total, 10,186 women aged …

Background: High-risk human papillomavirus (hrHPV)-based cervical cancer screening in
the Netherlands led to a substantial increase in number of colposcopy referrals and low …

Background: Recommendations for high-risk human papillomavirus (HR-HPV) testing as an
adjunct to cytology for cervical cancer screening differ by age group, because HR-HPV tests …